Atovaquone proguanil hydrochloride

Revision as of 18:00, 7 January 2014 by Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{XXXXX}} {{CMG}} ==Overview== ==Category== ==US Brand Names== MALARONE<sup>®</sup> ==FDA Package Insert== ''' Description''' '''| XXXX...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Category

US Brand Names

MALARONE®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages

Mechanism of Action

References

Retrieved from "https://www.wikidoc.org/index.php?title=Atovaquone_proguanil_hydrochloride&oldid=927524"